T1	HMM 9 17	survival
T2	HMM 386 411	efficacy and tolerability
T3	HMM 806 814	efficacy
T4	HMM 818 851	time to disease progression (TTP)
T5	HMM 957 973	overall survival
T6	HMM 1063 1092	objective tumor response rate
T7	HMM 1139 1191	Gastrointestinal side effects and hand-foot syndrome
T8	HMM 1243 1262	myalgia, arthralgia
T9	HMM 1268 1292	neutropenic fever/sepsis
T10	HMM 1344 1366	grade 3 adverse events
T11	HMM 1436 1450	grade 4 events
T12	HMM 1560 1576	TTP and survival
T13	HMM 1665 1681	toxicity profile
